Created by CuratorMaster
Dementia research, caregiver support, and hope
Explore the latest content tracked by Caring for Those Who Cared for Us
After nearly two decades without new Alzheimer’s options, the FDA has approved Aducanumab and Lecanemab, both amyloid-targeting antibodies. This long-awaited progress brings tangible hope to patients and the families who care for them.
Caregivers can reduce fear by recognizing when memory changes might signal treatable conditions rather than inevitable decline. Dr. Ellison stresses...
Emerging research highlights practical nutrition and lifestyle approaches that may help protect brain health as we age, offering real hope for seniors...
AXS-05 approval marks a meaningful step forward for managing agitation in Alzheimer disease, with direct potential to reduce caregiver burden and...
Communities are rolling out accessible, no-cost resources to ease burnout and loneliness for dementia caregivers and grieving seniors.
A clear trend is emerging: seniors want brain health guidance but must drive the conversation while watching medication side effects.
Fresh legislative momentum and hands-on services are easing caregiver strain.
Both proven non-drug approaches and fast-moving science are creating real hope for dementia patients and caregivers right now.
Fresh research reveals practical ways to lower dementia risk while new tools unlock targeted treatments.
Families facing Alzheimer's need real resources to cope and connect.
Dementia support groups are emerging as a proven lifeline, blending emotional connection with measurable delays in nursing home placement.
Biomarker advances now allow cognitive function in aging to be understood through markers of brain injury and specific pathways. This progress supports targeted interventions that build resilience for healthier aging.
Combining provider expertise with caregiver empathy offers the most effective path forward.
Millions juggle jobs and caregiving, with 70% of those ages 18-64 balancing both. Denial often masks irritability, fatigue, and chronic stress that...
Simple daily habits may support brain health as we age. Two recent studies highlight promising patterns.
Donanemab and lecanemab were celebrated as potential breakthroughs yet ultimately do not work as hoped despite slowing early cognitive decline. Realistic expectations and further research remain essential.
Tau-PET imaging from IGC Pharma highlights advanced analytics that could transform Alzheimer's monitoring and patient stratification, opening doors to earlier interventions and more personalized care planning for families and caregivers.
Biogen is advancing diranersen, one of the more advanced tau-targeting therapies in development for Alzheimer's, even after the study missed its main...
